4.7 Article

Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients

Journal

KIDNEY INTERNATIONAL
Volume 79, Issue 7, Pages 749-756

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1038/ki.2010.487

Keywords

anorexia; appetite; leptin; malnutrition; outcome

Funding

  1. Amgen
  2. Heart and Lung Foundation
  3. Swedish Medical Research Council (VR)
  4. Karolinska Institutet's Diabetes Theme Center
  5. Swedish Kidney Association
  6. Loo and Hans Osterman's Foundations
  7. Baxter Healthcare

Ask authors/readers for more resources

Ghrelin abnormalities contribute to anorexia, inflammation, and cardiovascular risk in hemodialysis patients, leading to worse outcome. However, ghrelin levels are influenced by the nutritional status of the individual. We hypothesized that the consequences of ghrelin alterations in hemodialysis patients are context sensitive and dependent on the presence of protein-energy wasting (PEW). In this cross-sectional study of 217 prevalent hemodialysis patients followed for 31 months, we measured ghrelin, leptin, PEW (subjective global assessment), and C-reactive protein (an index of inflammation). Compared to patients in the middle and upper tertile of ghrelin levels, those in the lowest tertile were older, had higher leptin levels and body mass index, and presented an increased mortality risk that persisted after adjustment for age, gender, and dialysis vintage. This risk was lost after correction for comorbidities. Patients with PEW and low ghrelin values had abnormally high C-reactive protein and leptin by multivariate analysis of variance, and the highest mortality risk compared to non-PEW with high ghrelin from all-cause and cardiovascular-related mortality (adjusted hazard ratios of 3.34 and 3.54, respectively). Low ghrelin values in protein-energy wasted hemodialysis patients were linked to a markedly increased cardiovascular mortality risk. Thus, since these patients were more anorectic, our results provide a clinical scenario where ghrelin therapies may be particularly useful. Kidney International (2011) 79, 749- 756; doi: 10.1038/ki.2010.487; published online 22 December 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available